Virtu Financial LLC Dynavax Technologies Corp Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.94 - $9.1 $165,022 - $510,783	-56,130 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$3.46 - $6.93 $48,152 - $96,444	13,917 Added 32.97%	56,130 $321,000
Q3 2019 Nov 20, 2019	BUY	$2.69 - $4.85 $86,133 - $155,297	32,020 Added 314.14%	42,213 $151,000
Q2 2019 Aug 13, 2019	BUY	$3.65 - $7.89 $37,204 - $80,422	10,193 New	10,193 $41,000
Q1 2019 Apr 12, 2019	SELL	$7.08 - $12.09 $90,248 - $154,111	-12,747 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$8.14 - $13.28 $103,760 - $169,280	12,747 New	12,747 $117,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.